Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. - Wikidata - awgldk - TriplyDB

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

http://www.wikidata.org/entity/Q34982551

about

Toxicity of amphetamines: an update Pharmacotherapy for stimulant-related disorders Pharmacotherapy of amphetamine-type stimulant dependence: an update Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans Methamphetamine enhances paced mating behaviors and neuroplasticity in the medial amygdala of female rats Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence.Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future Retrotransposition of long interspersed element 1 induced by methamphetamine or cocaine.Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.Cigarette smoking and short-term addiction treatment outcome.A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram.The influence of dopamine receptor d4 polymorphism on resting EEG in healthy young females Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder.Androgen-primed castrate males are sufficient for methamphetamine-facilitated increases in proceptive behavior in female rats Enhanced extinction of cocaine seeking in brain-derived neurotrophic factor Val66Met knock-in mice Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells.Medications for substance use disorders (SUD): emerging approaches.Serotonin and Dopamine Candidate Gene Variants and Alcohol- and Non-Alcohol-Related Aggression.Polymorphisms of COMT Val158Met and DAT1 3'-UTR VNTR in illicit drug use and drug-related psychiatric disorders.Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population.Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats.The potential of pharmacogenomics to treat drug addiction.

P2860

Q22252794-DBF18672-65AD-4E6B-BEB8-97BD91C4B8E9 Q26829186-58CD3BB7-EF8E-49E5-B027-276147A14CA4 Q26991936-DCD34C4C-A317-416D-811A-17E2C4F23B63 Q27026214-0D702F8B-FFF3-431B-BF7B-4E424B4C001B Q28236333-DE1C7733-EF6B-4B49-903D-93F479B78AF1 Q28578936-AB98C9D0-FC92-4DF5-92AC-1D56A1CA4126 Q30524334-6D304A4A-DC0E-468B-9DD9-3A71A333B7F5 Q33671505-9C85D952-753A-4B4A-8E46-3F4C54674AC3 Q33995795-6694831D-620E-44BC-AE43-2DD6CBBB4119 Q34170616-921ABA34-C669-40CA-B133-65A851621808 Q34287658-3B44C6C7-3D33-4EE8-BEC0-27B43C5FA1FC Q34827624-DD16D35A-A0B4-4970-B102-E3C947A49A89 Q35489643-AA804E4D-A48C-409E-ABC7-C94793EF69E0 Q35841115-6F5ADEBB-8E96-4D3F-952F-6F366127C63C Q35934610-853E7B3E-01BC-4930-9020-973FB563E581 Q35995415-18B59ECE-2070-4201-B1BE-C0F7408A91ED Q36316106-335633FC-9648-4158-9A6D-D463909AF968 Q36479464-E7CF9121-ABF4-4E50-8052-540FD97BC5DD Q36765712-C2BB1BF2-7758-4A05-BE0E-BC71AAF566B2 Q36928468-A28F45A7-4039-4EE5-92C1-45B4E3CBD43D Q37425104-90958086-9D2A-4994-903E-6AA36CD697AD Q37453915-8E5DA735-1387-4B56-A1CE-17716325C1A9 Q39501491-A11E18FB-C6A4-436E-9DFC-C3F87A2E23C9 Q47731975-A9AC90F8-A34E-46C1-AB0F-18B189F380E6 Q48081384-54557060-6DF2-46AF-9A5C-83892237DD91 Q48318550-A92CD92F-9431-4F8C-A4F2-04BB739EC46F Q50552056-21B8FF2C-A7C7-41B6-BF7E-9617EB439AC9 Q51459211-191081B4-ED3B-45B9-AC80-ACE419851C48 Q52295623-7AF968EF-2653-46A3-8868-06A205CE3E88

P2860

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

http://www.wikidata.org/entity/Q34982551

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@ast

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@en

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@nl

type

label

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@ast

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@en

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@nl

prefLabel

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@ast

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@en

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@nl

P1433

Q34982551-B37E7112-3563-4872-B84B-F9FF228B6866

P1476

Q34982551-1D3B5014-0F3D-41B8-8FC8-8FE9370E6D60

P2093

Q34982551-1AA77C53-7B3A-481E-9A4C-0C063A2557CC

Q34982551-35660351-DE31-4341-A028-B45371E9729E

Q34982551-CC71110C-99C4-43C7-BCE1-7557FB218DA4

P2860

Q34982551-006118E8-097B-4529-853A-49CE98B09E1F

Q34982551-00D42B12-194F-45B6-AC1A-B51741086953

Q34982551-01393231-0D1B-4443-9F19-4CE006C6FA04

Q34982551-01F8C331-D397-46B8-A4BA-C37A206AD0E7

Q34982551-02049999-0717-4FCB-915A-D92C2D5EEE71

Q34982551-03C3DFA3-CD94-401D-ACA1-E9640288B3C4

Q34982551-04DD43D1-9D19-41C1-AC9B-D44B6BBAE61F

Q34982551-05DD60D4-5168-4118-BEAB-78B99AAC4944

Q34982551-080A95F7-F738-4670-A439-0FE54A6DC522

Q34982551-09D70908-54F9-44F2-8E39-0E17750EFBE1

P304

Q34982551-2C1CEB32-9F30-457C-93C5-206BF608BEDE

P31

Q34982551-34B90AFA-7CEE-40CB-93B9-00B90D4C6CDF

P356

Q34982551-D6BBF504-DA74-4C33-9A3A-7169BADF86B9

P433

Q34982551-B6070408-1B6E-4822-909D-AC298DB19720

P478

Q34982551-FA6E6046-372E-446B-A7EF-75E584DFFE4E

P577

Q34982551-DAA66786-234A-43B6-B80F-7C374BBCEF01

P5875

Q34982551-2E1DBAC6-D112-4AB1-BED0-79D6326A1879

P698

Q34982551-6EB70904-D203-4B18-ACBD-6618509F870B

P921

Q34982551-32231DB1-8245-48F3-8B93-ADF65C210F17

P932

Q34982551-7DBF9B6A-C92C-41B8-9AF7-843AF043B89D

P356

00952990902825447

P1433

American Journal of Drug and Alcohol Abuse

P1476

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

@en

P2093

Colin N Haile

http://www.w3.org/2001/XMLSchema#string

Therese A Kosten

http://www.w3.org/2001/XMLSchema#string

Thomas R Kosten

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine beta-hydroxylase deficiency

Addiction and the brain: The neurobiology of compulsion and its persistence

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids

Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers

The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

P304

161-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00952990902825447

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24446380

http://www.w3.org/2001/XMLSchema#string

P698

19462300

http://www.w3.org/2001/XMLSchema#string

P921

substance dependence

P932

2754046

http://www.w3.org/2001/XMLSchema#string